Handelsbanken Fonder Ab Halozyme Therapeutics, Inc. Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

A detailed history of Handelsbanken Fonder Ab transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 1,969,169 shares of HALO stock, worth $92.5 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

1,969,169

Previous 1,112,969 76.93%

Holding current value

$92.5 Million

Previous $58.3 Million 93.42%

% of portfolio

0.45%

Previous 0.25%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	BUY	$51.3 - $64.42 $43.9 Million - $55.2 Million	856,200 Added 76.93%	1,969,169 $113 Million
Q2 2024 Aug 05, 2024	BUY	$37.81 - $52.4 $10.7 Million - $14.9 Million	284,300 Added 34.31%	1,112,969 $58.3 Million
Q1 2024 May 13, 2024	BUY	$33.68 - $41.95 $19.6 Million - $24.4 Million	582,600 Added 236.76%	828,669 $33.7 Million
Q4 2023 Feb 01, 2024	BUY	$33.32 - $42.1 $7.4 Million - $9.35 Million	222,200 Added 930.91%	246,069 $9.1 Million
Q3 2023 Oct 19, 2023	BUY	$36.46 - $44.03 $65,628 - $79,254	1,800 Added 8.16%	23,869 $912,000
Q2 2023 Aug 02, 2023	SELL	$30.28 - $38.74 $7.57 Million - $9.69 Million	-250,000 Reduced 91.89%	22,069 $796,000
Q1 2023 Apr 28, 2023	BUY	$32.86 - $55.7 $8.26 Million - $14 Million	251,400 Added 1216.31%	272,069 $10.4 Million
Q2 2022 Aug 03, 2022	SELL	$37.35 - $48.3 $108,315 - $140,070	-2,900 Reduced 12.3%	20,669 $909,000
Q1 2022 May 11, 2022	SELL	$31.97 - $41.06 $156,653 - $201,194	-4,900 Reduced 17.21%	23,569 $940,000
Q2 2021 Aug 03, 2021	BUY	$38.84 - $51.31 $194,200 - $256,550	5,000 Added 21.3%	28,469 $1.29 Million
Q1 2021 Apr 29, 2021	SELL	$39.51 - $51.45 $280,521 - $365,295	-7,100 Reduced 23.23%	23,469 $978,000
Q4 2020 Feb 11, 2021	SELL	$25.81 - $43.62 $263,262 - $444,924	-10,200 Reduced 25.02%	30,569 $1.31 Million
Q2 2020 Aug 13, 2020	BUY	$16.25 - $26.81 $662,496 - $1.09 Million	40,769 New	40,769 $1.09 Million

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.54B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Halozyme Therapeutics, Inc. Transaction History